Ventyx Biosciences, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ACLX
|
Arcellx, Inc. | $82.13 | $2.72 B | -49.3 | 130 | $110.32 M |
 ASND
|
Ascendis Pharma A/S | $126.86 | $7.77 B | -14.19 | 879 | $266.72 M |
 CERE
|
Cerevel Therapeutics Holdings, Inc. | $44.96 | $7.29 B | -14.66 | 355 | $0 |
 DICE
|
DICE Therapeutics, Inc. | $47.55 | $2.27 B | -21.91 | 71 | $0 |
 GPCR
|
Structure Therapeutics Inc. | $39.36 | $2.47 B | -23.59 | 136 | $0 |
 IDYA
|
IDEAYA Biosciences, Inc. | $29.08 | $2.88 B | -19 | 124 | $23.39 M |
|
IMCR
|
Immunocore Holdings plc | $30.90 | $2.08 B | -26.72 | 497 | $249.43 M |
 NUVL
|
Nuvalent, Inc. | $88.92 | $5.11 B | -32.72 | 115 | $0 |
 PCVX
|
Vaxcyte, Inc. | $105.66 | $7.72 B | -16.54 | 254 | $0 |
|
PTGX
|
Protagonist Therapeutics, Inc. | $45.77 | $2.04 B | 13.7 | 125 | $60.00 M |
 REPL
|
Replimune Group, Inc. | $12.28 | $485.18 M | -2.44 | 331 | $0 |
 SNDX
|
Syndax Pharmaceuticals, Inc. | $19.04 | $1.66 B | -6.02 | 184 | $0 |
 TVTX
|
Travere Therapeutics, Inc. | $17.70 | $542.80 M | -1.32 | 380 | $145.24 M |
 UTHR
|
United Therapeutics Corporation | $380.10 | $12.20 B | 13.02 | 1168 | $2.33 B |
 VRNA
|
Verona Pharma plc | $39.05 | $983.52 M | -15.16 | 79 | $0 |